Form 4: Avalo Therapeutics CFO Christopher Sullivan Reports Stock Transactions
SEC Form 4
Christopher Ryan Sullivan, CFO of Avalo Therapeutics, reports the acquisition and disposal of common stock and restricted stock units on March 28, 2025.
Summary
- Christopher Ryan Sullivan, the Chief Financial Officer of Avalo Therapeutics, Inc. [AVTX], filed a Form 4 on April 1, 2025, reporting transactions in the company's securities.
- On March 28, 2025, Sullivan exercised restricted stock units, converting 24,200 units into 24,200 shares of common stock.
- Also on March 28, 2025, Sullivan disposed of 7,285 shares of common stock at a price of $8.46 per share.
- Following these transactions, Sullivan directly owns 16,921 shares of Avalo Therapeutics common stock and 48,400 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions by a company insider. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a key executive.
Key Dates
| Date | Description |
|---|---|
| 08/13/2024 | Reporting Person was granted 72,600 restricted stock units |
| 03/28/2025 | Restricted stock units converted into common stock; shares disposed of |
| 03/28/2026 | Next vesting date for restricted stock units |
| 03/28/2027 | Final vesting date for restricted stock units |
| 04/01/2025 | Date of Form 4 filing |
Keywords
Form 4, insider trading, stock disposal, restricted stock units, AVTX, Avalo Therapeutics, Christopher Ryan Sullivan, CFO, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.